Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.44 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.44 |
| ▸ | CCNK | O75909 | 2/20 | 0.42 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.42 |
| ▸ | ITK | Q08881 | 6/20 | 0.40 |
| ▸ | EGFR | P00533 | 12/20 | 0.39 |
| ▸ | JAK3 | P52333 | 3/20 | 0.37 |
| ▸ | JAK2 | O60674 | 2/20 | 0.37 |
| ▸ | FLT3 | P36888 | 2/20 | 0.37 |
| ▸ | BLK | P51451 | 2/20 | 0.37 |
| ▸ | BTK | Q06187 | 2/20 | 0.37 |
| ▸ | PLK4 | O00444 | 1/20 | 0.37 |
| ▸ | GAK | O14976 | 1/20 | 0.37 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.37 |
| ▸ | BMX | P51813 | 1/20 | 0.37 |
| ▸ | CTSC | P53634 | 1/20 | 0.37 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.37 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.37 |
| ▸ | DCLK3 | Q9C098 | 1/20 | 0.37 |
| ▸ | NUAK2 | Q9H093 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18060663 | 0.87 | CCNK (0.43) | EHMT2EHMT1CCNKCDK12ITK | |
| SCHEMBL18060652 | 0.85 | EHMT2 (0.44) | EHMT2EHMT1CCNKCDK12ITK | |
| SCHEMBL18060779 | 0.82 | EHMT2 (0.43) | EHMT2EHMT1CCNKCDK12ITK | |
| SCHEMBL18060720 | 0.78 | UCHL3 (0.51) | ITKEGFRJAK3JAK2FLT3 | |
| SCHEMBL12805653 | 0.74 | EHMT2 (0.44) | EHMT2EHMT1CCNKCDK12ITK | |
| SCHEMBL12805448 | 0.73 | EHMT2 (0.47) | EHMT2EHMT1CCNKCDK12ITK | |
| SCHEMBL12806022 | 0.69 | EHMT2 (0.45) | EHMT2EHMT1CCNKCDK12ITK | |
| SCHEMBL18060908 | 0.69 | CTSC (0.48) | ITKEGFRJAK3JAK2FLT3 | |
| SCHEMBL12806084 | 0.68 | UCHL3 (0.51) | EHMT2EHMT1ITKEGFRJAK3 | |
| SCHEMBL18060751 | 0.68 | EGFR (0.49) | EGFRJAK3JAK2BTKJAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3205647-B1 | 2-(PYRIMIDIN-5-YL)-THIOPYRIMIDINE DERIVATIVES AS HSP70 AND HSC70 MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2020-05-13 | — | — | EP | disclosed |
| EP-3205647-A2 | 2-(PYRIMIDIN-5-YL)-THIOPYRIMIDINE DERIVATIVES AS HSP70 AND HSC70 MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | Memorial Sloan-Kettering Cancer Center (US) | 2017-08-16 | — | — | EP | disclosed |
| EP-2467142-B1 | 2-(Pyrimidin-5-yl)-thiopyrimidine derivatives as Hsp70 and Hsc70 modulators for the treatment of proliferative disorders | SLOAN KETTERING INST CANCER (US) | 2016-09-21 | — | — | EP | disclosed |